bpc 157 human clinical trials safety The Stable Gastric Pentadecapeptide Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity bpc-157 human clinical trials evidence

For other imaging modalities like dopamine transporter (DAT)-scan, Fluorodeoxyglucose Positron-emission tomography (FDG PET), and F-Dopa PET, published data is scarce

a proportion of patients with Parkinson's disease develop dementia Cognitive impairment also occurs in the Parkinson-plus syndromes of progressive supranuclear palsy and corticobasal degeneration (and the same underlying pathology may cause the clinical syndromes of frontotemporal lobar degeneration)

First, it was retrospective, which means it relied on patients recalling their experiences months laterthis is far less reliable than a controlled, prospective study

However, those searches are usually consumer-style searches